Related Experiment Video
Updated: Jul 6, 2026
07:41
Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice
Published on: June 8, 2022
Redox imbalance in Parkinson's disease
Shankar J Chinta1, Julie K Andersen
1Buck Institute for Age Research, Novato, California 94945, USA.
Biochimica Et Biophysica Acta
|March 25, 2008
Summary
Oxidative stress contributes to Parkinson's disease (PD) by damaging dopamine neurons. Antioxidant therapies targeting reactive oxygen species (ROS) and iron may slow PD progression.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Parkinson's disease (PD) involves the loss of dopamine neurons in the substantia nigra (SN), leading to Lewy bodies.
- While mostly sporadic, PD has familial forms, with the exact cause of selective cell death remaining unknown.
- Oxidative stress is strongly implicated in the pathogenesis of Parkinson's disease.
Purpose of the Study:
- To review the sources of reactive oxygen species (ROS) contributing to redox imbalance in PD.
- To identify potential therapeutic targets for mitigating oxidative stress in Parkinson's disease.
Main Methods:
- Literature review summarizing current research on oxidative stress in PD.
- Analysis of mechanisms contributing to oxidative damage in dopaminergic neurons.
Main Results:
- Dopamine metabolism, auto-oxidation, iron accumulation, reduced glutathione, and mitochondrial dysfunction increase ROS production in the SN.
- These factors collectively overwhelm the antioxidant capacity of dopamine neurons, leading to cell death.
- Elevated oxidative stress is a key factor in the selective vulnerability of dopaminergic neurons in PD.
Conclusions:
- Enhancing antioxidant defenses and reducing labile iron pools in the SN are promising therapeutic strategies for PD.
- Targeting ROS and redox imbalance offers a rational approach to slow or prevent neurodegeneration in Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:27Redox Reactions
Redox reactions are vital biochemical processes that underpin energy metabolism in cells. These reactions involve the transfer of electrons between molecules, occurring in tandem as oxidation and reduction. Oxidation refers to the loss of electrons, while reduction denotes their gain. This coupling ensures the seamless flow of electrons through metabolic pathways. For example, in bacterial metabolism, glucose undergoes oxidation to carbon dioxide, while oxygen is simultaneously reduced to...
01:24Redox Reactions
Oxidation-reduction or redox reactions involve the transfer of electrons from one molecule or atom to another. When an atom gains an electron, another atom must lose an electron, meaning oxidation and reduction must occur together. Since the redox occurs in pairs, the atom that gets oxidized is also called the reducing agent or reductant, and the atom that is reduced is also called the oxidizing agent or oxidant. A straightforward way to remember the definitions of oxidation and reduction is...